Roberto Bini
Roberto Bini is the Director of Cardiology at a medical facility in San Marino, known for his expertise in treating rare cardiac diseases, particularly hypertrophic obstructive cardiomyopathy. Recently, he has been in the news for his involvement in the treatment of patients with this condition using Mavacamten, an innovative medication that has shown promising results in improving patient outcomes and quality of life. Bini emphasizes the significance of this new therapy, which offers a less invasive alternative to traditional treatments and holds potential for extending patients' life expectancy.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| San Marino | 1 | 8.00 | 0.10% | +0% | 33,938 | 35 | $2,000 | 2$ |
| Totals | 1 | 33,938 | 35 | $2,000 | 2$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
San Marino:
Roberto Bini is the director of the UOC of Cardiology and highlights the underestimation of cardiovascular risk factors in women.
8
San Marino:
Roberto Bini is the Director of Cardiology who discusses the innovative drug Mavacamten and its impact on patients.
9